找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Genome Editing in Biomedical Sciences; Geraldo A. Passos Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens

[复制链接]
查看: 46291|回复: 42
发表于 2025-3-21 16:53:09 | 显示全部楼层 |阅读模式
书目名称Genome Editing in Biomedical Sciences
编辑Geraldo A. Passos
视频video
概述Written by global experts in the evolving field of CRISPR genome editing.Provides timely overview of recent developments in the field, new technologies, and methodologies.Discusses ethical issues and
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Genome Editing in Biomedical Sciences;  Geraldo A. Passos Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens
描述.This volume focuses on applying the Crispr system in editing the genome of human cells (.in vitro. and .in vivo.) and model organisms used in biomedical research. With the advent of Crispr technology, genome editing soon became a procedure of great interest to laboratories worldwide due to its relative ease and accuracy. In biomedical sciences, genome editing by Crispr has already enabled the development of new experimental model systems. In medicine, therapeutic alternatives for the genetic "correction" of diseases have already begun to appear. Therefore, the book‘s purpose is to bring in a single volume, chapters that show the scientific community in biomedicine, medicine, human genetics, oncology, virology, and parasitology, among others, the advances in genomic editing. In a chapter dedicated to the ethical aspects of human genomic editing, we also address what we can and should do with this (bio)technology. The book chapters were written by productive researchers specializing in Crispr genome editing. The chapters cover the concept of Crispr and genome editing and how to use this new methodology in biomedical research and medicine, among other aspects, including the ethical c
出版日期Book 2023
关键词Crispr; Crispr-Cas9; gene therapy; human genome; gene regulation; biomedical research; biotechnology; oncol
版次1
doihttps://doi.org/10.1007/978-3-031-33325-5
isbn_ebook978-3-031-33325-5Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Genome Editing in Biomedical Sciences影响因子(影响力)




书目名称Genome Editing in Biomedical Sciences影响因子(影响力)学科排名




书目名称Genome Editing in Biomedical Sciences网络公开度




书目名称Genome Editing in Biomedical Sciences网络公开度学科排名




书目名称Genome Editing in Biomedical Sciences被引频次




书目名称Genome Editing in Biomedical Sciences被引频次学科排名




书目名称Genome Editing in Biomedical Sciences年度引用




书目名称Genome Editing in Biomedical Sciences年度引用学科排名




书目名称Genome Editing in Biomedical Sciences读者反馈




书目名称Genome Editing in Biomedical Sciences读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:11:38 | 显示全部楼层
https://doi.org/10.1007/978-3-531-90712-3We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.
发表于 2025-3-22 03:26:20 | 显示全部楼层
Genome Editing Tools for Lysosomal Storage Disorders,We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.
发表于 2025-3-22 07:00:48 | 显示全部楼层
发表于 2025-3-22 08:52:01 | 显示全部楼层
发表于 2025-3-22 13:24:55 | 显示全部楼层
,Friendship in the Fathers’ Later Lives,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).
发表于 2025-3-22 18:48:37 | 显示全部楼层
The CRISPR/Cas System in Human Cancer,llular and animal model generation, and new derivative tools applied to cancer research. CRISPR has opened new frontiers increasing the knowledge about cancer, pointing to new solutions to overcome several challenges to better understand the disease and design better treatments.
发表于 2025-3-23 01:13:46 | 显示全部楼层
Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).
发表于 2025-3-23 03:58:36 | 显示全部楼层
Joanne M. McKeown,Catherine G. FineNA targeting in tumorigenesis and drug resistance. Additionally, we highlighted the perspectives and potential applications of CRISPR approaches to treat cancer, as an emerging and promising target therapy.
发表于 2025-3-23 06:06:38 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-8 01:23
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表